Combination of RT and ASC-J9® treatment represents a new effective therapeutic strategy to suppress PCa progression. 1. Introduction Prostate cancer (PCa), a common cancer among men worldwide, has been incre
Levels of PSA, a protein produced by both normal and cancerous cells in the prostate gland, are often elevated in men with prostate cancer. As such, PSA is frequently used as both a screening tool and a biomarker to assess whether men with the disease might be responding to treatment. How...